{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030229",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030229_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\">Varicella-zoster immunoglobulin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the efficacy of</ph> <ph otherprops=\"Bacillus Calmette-Guérin vaccine\" outputclass=\"int-drug\">Bacillus Calmette-Guérin vaccine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for at least 3 months after stopping <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/varicella-zoster-immunoglobulin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8476\">varicella-zoster immunoglobulin</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Varicella-zoster immunoglobulin   is predicted to   decrease   the efficacy of   Bacillus Calmette-Guérin vaccine .  Manufacturer advises avoid and for at least 3 months after stopping  varicella-zoster immunoglobulin .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bacillus Calmette-Guérin vaccine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030230",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030230_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\">Varicella-zoster immunoglobulin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the efficacy of</ph> <ph otherprops=\"herpes-zoster vaccine, live\" outputclass=\"int-drug\">herpes-zoster vaccine, live</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for 3 months after stopping <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/varicella-zoster-immunoglobulin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8476\">varicella-zoster immunoglobulin</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Varicella-zoster immunoglobulin   is predicted to   decrease   the efficacy of   herpes-zoster vaccine, live .  Manufacturer advises avoid and for 3 months after stopping  varicella-zoster immunoglobulin .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Herpes-zoster vaccine, live</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030231",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030231_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\">Varicella-zoster immunoglobulin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the efficacy of</ph> <ph otherprops=\"influenza vaccine (live)\" outputclass=\"int-drug\">influenza vaccine (live)</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for at least 3 months after stopping <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/varicella-zoster-immunoglobulin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8476\">varicella-zoster immunoglobulin</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Varicella-zoster immunoglobulin   is predicted to   decrease   the efficacy of   influenza vaccine (live) .  Manufacturer advises avoid and for at least 3 months after stopping  varicella-zoster immunoglobulin .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Influenza vaccine (live)</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030232",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030232_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\">Varicella-zoster immunoglobulin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">efficacy</ph> <ph otherprops=\"measles, mumps and rubella vaccine, live\" outputclass=\"int-drug\">measles, mumps and rubella vaccine, live</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for at least 3 months after stopping <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/varicella-zoster-immunoglobulin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8476\">varicella-zoster immunoglobulin</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Varicella-zoster immunoglobulin   is predicted to   decrease   efficacy   measles, mumps and rubella vaccine, live .  Manufacturer advises avoid and for at least 3 months after stopping  varicella-zoster immunoglobulin .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Measles, mumps and rubella vaccine, live</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030233",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030233_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\">Varicella-zoster immunoglobulin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the efficacy of</ph> <ph otherprops=\"rotavirus vaccine\" outputclass=\"int-drug\">rotavirus vaccine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for at least 3 months after stopping <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/varicella-zoster-immunoglobulin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8476\">varicella-zoster immunoglobulin</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Varicella-zoster immunoglobulin   is predicted to   decrease   the efficacy of   rotavirus vaccine .  Manufacturer advises avoid and for at least 3 months after stopping  varicella-zoster immunoglobulin .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rotavirus vaccine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030234",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030234_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\">Varicella-zoster immunoglobulin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the efficacy of</ph> <ph otherprops=\"typhoid vaccine, oral\" outputclass=\"int-drug\">typhoid vaccine, oral</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for at least 3 months after stopping <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/varicella-zoster-immunoglobulin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8476\">varicella-zoster immunoglobulin</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Varicella-zoster immunoglobulin   is predicted to   decrease   the efficacy of   typhoid vaccine, oral .  Manufacturer advises avoid and for at least 3 months after stopping  varicella-zoster immunoglobulin .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Typhoid vaccine, oral</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030235",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2#bnf_i1643858030235_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\">Varicella-zoster immunoglobulin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the efficacy of</ph> <ph otherprops=\"varicella-zoster vaccine\" outputclass=\"int-drug\">varicella-zoster vaccine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for at least 3 months after stopping <ph otherprops=\"varicella-zoster immunoglobulin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/varicella-zoster-immunoglobulin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP8476\">varicella-zoster immunoglobulin</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Varicella-zoster immunoglobulin   is predicted to   decrease   the efficacy of   varicella-zoster vaccine .  Manufacturer advises avoid and for at least 3 months after stopping  varicella-zoster immunoglobulin .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Varicella-zoster vaccine</title>"
					}
				}
			],
			"hasSearchLabel": " Varicella-zoster immunoglobulin  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/varicella-zoster-immunoglobulin-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Varicella-zoster immunoglobulin </title>"
			},
			"rdfs:label": "varicella-zoster immunoglobulin"
		}
	]
}